Gara Jalqabaatti › Interdigitating Dendritic Cell Sarcoma › New York
Qorannoo klinikaalii Interdigitating Dendritic Cell Sarcoma New York keessatti
Qorannoo 3 Interdigitating Dendritic Cell Sarcoma f New York keessatti hirmaatuu jiru.
Magaalota New York keessatti
Takkalaa qorannoo (Ingiliffa)
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Cancer Center - Bergen, New York
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07121946A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Mud-2025 · NCT06736613Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Onk-2025 · NCT05940272Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.